[Pleurodesis technique in malignant pleural effusion].
Malignancy is the leading cause of exudative pleural effusion in patients over 60. Several techniques for palliative treatment of malignant pleural effusions (MPE) are recommended; in particular, sclerosing agents have been instilled into the pleural cavity. In up to 30%, recurrence of MPE cannot be prevented. In recent years excellent results (recurrence rate less than 10%) have been reported using the technique of thoracoscopic talkage. After a review of the most frequent techniques of pleurodesis, a treatment strategy, mentioning the indications for the thoracoscopic procedure, is presented stressing the following guidelines: after complete thoracocentesis the patient's respiratory symptoms should decrease significantly and the compressed lung must be expanded clinically and radiologically after drainage. For patients fulfilling these conditions thoracoscopic pleurodesis is an effective initial treatment. It seems to be a safe procedure with minor side effects even for patients in a reduced general condition.
Furrer
M
M
Universitätsklinik für Thorax-, Herz- und Gefässchirurgie, Inselspital Bern.
Inderbitzi
R
R
D000970:Antineoplastic Agents / Q000008:administration & dosage; D004322:Drainage; D015718:Fibrin Tissue Adhesive / Q000008:administration & dosage; D006801:Humans; D016066:Pleural Effusion, Malignant / Q000628:therapy*; D015911:Sclerotherapy / Q000379:methods*; D013627:Talc / Q000627:therapeutic use*; D013752:Tetracycline / Q000008:administration & dosage
D000970:Antineoplastic Agents; D015718:Fibrin Tissue Adhesive; D013627:Talc; D013752:Tetracycline
Pleurodeseverfahren beim malignen Pleuraerguss.